EUVIMEDEUVIMED entdecken
Crossref

The Impact of Time-in-Target Range for Systolic Blood Pressure on Left Ventricular Hypertrophy

Jianjiao Wang, Wen Li, Man Gui, Yang Liu, Siyu Wang, Shouling Wu, Wei Huang iD

American Journal of Hypertension · 2025

DOI: 10.1093/ajh/hpaf141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hypertension, 2025. Verfasst von Jianjiao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of the First Clinical Medical School, Hebei North University, Zhangjiakou, Hebei, China. Hauptthemen laut MEDLINE: Hypertrophy, Left Ventricular, Blood Pressure, Hypertension, Antihypertensive Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND We aimed to explore the association between systolic blood pressure time-in-target range (SBP-TTR) and left ventricular hypertrophy (LVH). METHODS A total of 33,818 participants of the Kailuan Study who underwent echocardiography and had participated in at least two health checkups between 2006 and 2020. The target SBP ranges are defined as 120–140 and 110–130 mmHg, respectively. SBP-TTR was calculated by linear interpolation. Poisson regression models were used to assess relative risk (RR) and 95% confidence intervals (CIs) for the associations of 120–140 and 110–130 mmHg SBP-TTR with LVH. RESULTS When the SBP target range was defined as 120–140 mmHg, in multivariable-adjusted models, compared to the reference group (SBP-TTR ≤25%), LVH risk was significantly reduced in the 75% < SBP-TTR ≤ 100% group, (RR: 0.94, 95% CI: 0.89–0.99). When the SBP target range was defined as 110–130 mmHg, compared to the reference group (SBP-TTR ≤25%), there was significantly reduced in LVH risk in the 25% < SBP-TTR ≤ 50% (RR: 0.89, 95%CI: 0.83-0.94), 50%<SBP-TTR ≤ 75% (RR: 0.85, 95%CI: 0.79-0.91) and 75%< SBP-TTR ≤ 100% (RR: 0.81, 95%CI: 0.76–0.86) groups. Analysis using restricted cubic splines revealed a linear, dose–response relationship between SBP-TTR and LVH risk. CONCLUSIONS With increased SBP-TTR associated with a reduced risk of LVH, demonstrating a clear dose–response relationship. Compared to an SBP-TTR range of 120–140 mmHg, maintaining SBP-TTR at 110–130 mmHg more effectively reduces LVH risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertrophy, Left VentricularBlood PressureHypertensionAntihypertensive AgentsHumansMaleFemaleMiddle AgedAgedTime FactorsEchocardiographyChinaRisk AssessmentRisk FactorsSystoleAdult

Stichwörter der Autor:innen

Kailuan studyblood pressurehypertensionleft ventricular hypertrophytime-in-target range for systolic blood pressure

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Graduate School of the First Clinical Medical School, Hebei North University, Zhangjiakou, Hebei, China.
  • Department of Ultrasound, KaiLuan General Hospital, Tangshan, Hebei, China.
  • Department of Graduate School, Tianjin Medical University, Tianjin, China.
  • Department of Nursing, School of Nursing and Rehabilitation, North China University of Science and Technology, Tangshan, Hebei, China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
  • Department of Cardiology, Kailuan General Hospital, Tangshan, Hebei, China.

ORCID-Profile: Wei Huang

Zitieren

APA

Wang, J., Li, W., Gui, M., Liu, Y., Wang, S., Wu, S., & Huang, W. (2025). The Impact of Time-in-Target Range for Systolic Blood Pressure on Left Ventricular Hypertrophy. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf141

Vancouver

Wang J, Li W, Gui M, Liu Y, Wang S, Wu S, et al. The Impact of Time-in-Target Range for Systolic Blood Pressure on Left Ventricular Hypertrophy. American Journal of Hypertension. 2025. doi:10.1093/ajh/hpaf141

BibTeX
@article{Wang2025,
  author = {Wang, Jianjiao and Li, Wen and Gui, Man and Liu, Yang and Wang, Siyu and Wu, Shouling and Huang, Wei},
  title = {The Impact of Time-in-Target Range for Systolic Blood Pressure on Left Ventricular Hypertrophy},
  journal = {American Journal of Hypertension},
  year = {2025},
  doi = {10.1093/ajh/hpaf141}
}
Kostenlos starten →